SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-22-024983
Filing Date
2022-05-10
Accepted
2022-05-09 20:43:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 BAC'S ANNOUNCEMENT OF S-4 EFFECTIVENESS AND CEF ea159627-425_biotechacq.htm 425 29394
2 GRAPHIC image_001.jpg GRAPHIC 35968
  Complete submission text file 0001213900-22-024983.txt   80638
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filed by) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Subject) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39935 | Film No.: 22906971
SIC: 2834 Pharmaceutical Preparations